Category Archives: Health

AbbVie today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

AbbVie today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

In this interview, News-Medical speaks to Zoë Thomson, Co-founder and Chief Innovation Officer of LUCID, about how music and machine learning are changing how we approach mental and neuropsychiatric health.

A new retrospective study examines the effect of bisphosphonates on COVID-19 outcomes.

A recent meta-analysis aimed to describe the relationship between C-reactive protein levels and erectile dysfunction.

The Prime Minister has announced £25 million of UK aid backing for a new fund to ensure the world is better prepared to defeat future pandemics.

How long someone lives with Parkinson’s disease may be down to specific gene mutations, according to new research presented today at the 8th European Academy of Neurology Congress.

The Interactive Talk presentation, “Predicting Oral Cancer Risk using Machine Learning”, will take place on Saturday, June 25th, 2022 at 2 p.m. China Standard Time (UTC+08:00) during the “e-Oral Health Network I” session.

The Interactive Talk presentation, “Artificial Intelligence and non-/micro-invasive was cost-effective in a Randomized Trial”, will be presented by Falk Schwendicke, Charite – Universitaetsmedizin Berlin, Germany and take place on Saturday, June 25th, 2022 at 2 p.m. China Standard Time (UTC+08:00) during the “e-Oral Health Network I” session.

Tau hyperphosphorylation is the key characteristic pathological hallmarks of Alzheimer’s disease (AD). Recently studies showed periodontitis and periodontal pathogen are significant risk factors for AD.